Position in NTRA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$16,546,572
+$10,086,234 QoQ
Shares Held
82,737
+193.4% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $138,831,302 across 11 Diagnostics & Research names. NTRA ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
57,814 | $28,417,315 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
121,405 | $20,704,408 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
29,531 | $16,593,173 | |
| 4 | NTRA |
Natera, Inc.
This page
|
82,737 | $16,546,572 | |
| 5 | LH |
Labcorp Holdings Inc.
|
54,662 | $14,584,368 | |
| 6 | DHR |
Danaher Corp /De/
|
76,642 | $14,531,323 | |
| 7 | A |
Agilent Technologies, Inc.
|
101,500 | $11,568,970 | |
| 8 | ILMN |
Illumina, Inc.
|
84,137 | $10,370,726 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,546,572 | 82,737 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,460,338 | 28,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,798,892 | 23,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,632,210 | 21,500 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,563,532 | 25,200 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||